Adline Chem Lab last traded at ₹15.79 (2026-10-13). Over the past month the stock moved +37.1%, three months the stock moved +15.3%, year the stock moved -2.6%. Its closing range over 52 weeks is ₹7.60 – ₹15.79, with the latest close at its 52-week high.
Closing prices up to 2026-10-13.
Incorporated in 1988, Adline Chem Lab Ltd trades in pharmaceutical formulations, Nutraceutical, and Dietary products.[1]
Business Overview:[1] ACLL is in the business of manufacturing pharmaceutical chemicals, fine chemicals, and agrochemical products.
In the latest quarter (Jun 2026), Adline Chem Lab reported sales of ₹0.00 crore and net profit of ₹0.04 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.04 | – | 0.04 | 0.07 |
| Mar 2026 | 0.00 | -0.08 | – | -0.09 | -0.15 |
| Dec 2025 | 0.00 | -0.03 | – | -0.06 | -0.10 |
| Sep 2025 | 0.00 | -0.05 | – | -0.07 | -0.12 |
| Jun 2025 | 0.00 | -0.03 | – | -0.05 | -0.09 |
| Mar 2025 | 0.00 | -0.06 | – | 0.21 | 0.36 |
| Dec 2024 | 0.00 | -0.10 | – | -0.12 | -0.21 |
| Sep 2024 | 0.00 | -0.07 | – | -0.09 | -0.15 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | -142.9% | – |
| EPS growth | – | – | – | – | – | – | -141.7% | – |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Adline Chem Lab reported sales of ₹0.00 crore and net profit of ₹-0.28 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.00 | -0.15 | – | -0.28 | -0.48 |
| Mar 2025 | 0.00 | -0.30 | – | -0.13 | -0.22 |
| Mar 2024 | 0.00 | -0.18 | – | -0.27 | -0.46 |
| Mar 2023 | 0.00 | -0.80 | – | -4.23 | -7.23 |
| Mar 2022 | 0.74 | -0.30 | -40.54 | 0.72 | 1.23 |
| Mar 2021 | 6.33 | -0.23 | -3.63 | -1.28 | -2.19 |
| Mar 2020 | 6.59 | -3.32 | -50.38 | -3.76 | -6.43 |
| Mar 2019 | 5.59 | 0.58 | 10.38 | 0.03 | 0.05 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -31.0% | +17.9% | -3.9% | -88.3% | -100.0% | – | – | – |
| Operating profit growth | -33.3% | -672.4% | – | – | – | – | – | – |
| Net profit growth | – | -12633.3% | – | – | -687.5% | – | – | – |
| EPS growth | – | -12960.0% | – | – | -687.8% | – | – | – |
| OPM % | 10.4% | -50.4% | -3.6% | -40.5% | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Adline Chem Lab.
Get Free AI Stock Analysis FREE →Adline Chem Lab schedules Aug 27 board meeting to approve AGM notice - scanx.trade
Adline Chem Lab shares were last quoted at ₹15.79 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Adline Chem Lab has a price-to-earnings (P/E) ratio of -42.66 and a price-to-book (P/B) ratio of 0.00. The industry P/E is 53.45.
The 52-week high of Adline Chem Lab is ₹17.06 and the 52-week low is ₹7.60.
The market capitalisation of Adline Chem Lab is about ₹7.99 crore.
In the latest quarter (Jun 2026), Adline Chem Lab reported sales of ₹0.00 crore and net profit of ₹0.04 crore, compared with the same quarter last year.
Promoters hold about 25.85% of Adline Chem Lab.
Adline Chem Lab belongs to the Pharmaceuticals & Drugs sector.